Reply to Letter to the Editor "Sexual Dysfunction on Fluvoxamine Therapy"

View This PDF

NB: This article is only available as a PDF.

Letter to the Editor

Sir: We thank Dr. Laird for his thoughtful comments about our article. This study was an open-label clinical trial with fluvoxamine used as a hepatic enzyme inhibitor, as clearly stated in our Method section. The problems associated with open-label studies are well known, as are the benefits and problems associated with double- and triple-blind studies.

J Clin Psychiatry 2000;61(1):62-63